Cargando…

Bi-anti therapy for SARS-CoV-2 infection among mild/moderate patients to prevent coronavirus disease 2019 from progressing to severe disease

Detalles Bibliográficos
Autor principal:	Xu, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900530/ https://www.ncbi.nlm.nih.gov/pubmed/36747253 http://dx.doi.org/10.1186/s12967-023-03965-3

Ejemplares similares

Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan
por: Yan, Gabriel, et al.
Publicado: (2021)

Patient Perspectives on Anti-spike Monoclonal Antibody Therapy for Mild to Moderate Coronavirus Disease-2019
por: Razonable, Raymund R, et al.
Publicado: (2022)

Kidney manifestations of mild, moderate and severe coronavirus disease 2019: a retrospective cohort study
por: Hong, Daqing, et al.
Publicado: (2020)

Treatment Options for Patients With Mild-to-Moderate Coronavirus Disease 2019 in Korea
por: Jeon, Jaehyun, et al.
Publicado: (2022)

Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019—a multi-centre observational study
por: Cen, Y., et al.
Publicado: (2020)

Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort
por: Cheng, B., et al.
Publicado: (2020)

The added predictive role of echocardiography in patients with mild or moderate Coronavirus Disease 2019
por: Lupu, Lior, et al.
Publicado: (2023)

Anti-Spike Monoclonal Antibody Therapy in Pregnant Women With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)
por: Thilagar, Bright P., et al.
Publicado: (2022)

Severe coronavirus disease 2019 in children and young adults
por: Wilkes, Meredith, et al.
Publicado: (2020)

Platelet count in patients with severe coronavirus disease 2019
por: Kawada, Tomoyuki
Publicado: (2021)

Lymphocytes and Eosinophils Associated with the Coronavirus Disease-2019 Severity
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Use of Baricitinib in Patients With Moderate to Severe Coronavirus Disease 2019
por: Titanji, Boghuma K, et al.
Publicado: (2020)

Assessing viral shedding of SARS-CoV-2 in tears in Moderate to Severe coronavirus disease 2019 (COVID-19) patients.
por: Pumma, P., et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in peritoneal fluid of coronavirus disease 2019 (COVID-19) patients—Prevalence and significance
por: Seeliger, Barbara, et al.
Publicado: (2021)

Clinical features and mechanism of liver injury in patients with mild or moderate coronavirus disease 2019
por: Gomi, Kuniyo, et al.
Publicado: (2021)

Role of methyle blue in the management of mild, moderate and severe COVID-19 disease
por: Bawaskar, Himmatrao Saluba, et al.
Publicado: (2022)

Targeting complement in severe coronavirus disease 2019 to address microthrombosis
por: Valga, Francisco, et al.
Publicado: (2020)

Invasive pulmonary aspergillosis in severe coronavirus disease 2019 pneumonia
por: Lahmer, T., et al.
Publicado: (2020)

From coronavirus disease 2019 to long coronavirus disease 2019 in vascular pathology
por: Farinetti, Alberto, et al.
Publicado: (2022)

Coronavirus disease 2019 prevention, control and modelling metrics
por: Cariappa, M.P., et al.
Publicado: (2020)

Hydroxychloroquine in mild-to-moderate coronavirus disease 2019: a placebo-controlled double blind trial
por: Dubée, Vincent, et al.
Publicado: (2021)

Sequelae in adults at 12 months after mild‐to‐moderate coronavirus disease 2019 (COVID‐19)
por: Boscolo‐Rizzo, Paolo, et al.
Publicado: (2021)

Clinical Characteristics and Risk Prediction Score in Patients With Mild-to-Moderate Coronavirus Disease 2019 in Japan
por: Marumo, Atsushi, et al.
Publicado: (2022)

Asthma, from mild to severe, is an independent prognostic factor for mild to severe Coronavirus disease 2019 (COVID‐19)
por: Kwok, Wang Chun, et al.
Publicado: (2022)

Prevention, susceptibility, and clinical features of coronavirus disease 2019 in postoperative patients
por: Gao, Yuan, et al.
Publicado: (2020)

The role of a cytokine storm in severe coronavirus disease 2019 in pregnancy
por: Wang, Xiaoping, et al.
Publicado: (2020)

Dementia is Associated with Severe Coronavirus Disease 2019 (COVID-19) Infection
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2021)

Albumin and total bilirubin for severity and mortality in coronavirus disease 2019 patients
por: Wang, Ying, et al.
Publicado: (2020)

Hemoglobin value may be decreased in patients with severe coronavirus disease 2019
por: Lippi, Giuseppe, et al.
Publicado: (2020)

Cardiopulmonary Ultrasonography for Severe Coronavirus Disease 2019 Patients in Prone Position
por: Rali, Aniket S, et al.
Publicado: (2020)

Coronavirus disease 2019 and pregnancy
por: Rasmussen, Sonja A., et al.
Publicado: (2021)

Coronavirus disease 2019 in pregnancy
por: Tang, Mi, et al.
Publicado: (2021)

Reply to ‘Coronavirus disease 2019 prevention, control and modelling metrics’
por: Chatterjee, Kaushik, et al.
Publicado: (2020)

Progress in immunization of children against coronavirus disease 2019: The role of pediatric societies
por: Gallegos, Miguel, et al.
Publicado: (2022)

Cardiovascular Disease and Coronavirus Disease 2019: Epidemiology, Management, and Prevention
por: Ishigami, Junichi, et al.
Publicado: (2021)

Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
por: Tang, Wei, et al.
Publicado: (2020)

A Randomized Clinical Trial of Regdanvimab in High-Risk Patients With Mild-to-Moderate Coronavirus Disease 2019
por: Kim, Jin Yong, et al.
Publicado: (2022)

Rates of Severe Outcomes After Bamlanivimab-Etesevimab and Casirivimab-Imdevimab Treatment of High-Risk Patients With Mild to Moderate Coronavirus Disease 2019
por: O’Horo, John, et al.
Publicado: (2022)

Antibody responses to SARS-CoV-2 in patients with differing severities of coronavirus disease 2019
por: Kowitdamrong, Ekasit, et al.
Publicado: (2020)

Comments on: The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality
por: Maruotti, Antonello, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ngs69gnltb7gmd88n3o2jpui14